Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniele Oddo
Observed names:
ODDO, DANIELE,
Oddo, Daniele
Institution:
University of Turin
Observed institutions:
Candiolo Cancer Institute,
University of Turin
ORCID:
0000-0001-6179-1668
Observed ORCID:
0000-0001-6179-1668
OpenAlex ID:
A5067091212
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
2017
·
Ludovic Barault
, Alessio Amatu
, et al.
·
Gut
·
254
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF -Mutant Colorectal Cancer
2016
·
Daniele Oddo
, Erin M. Sennott
, et al.
·
Cancer Research
·
130
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2021
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
·
Cancer Discovery
·
124
PDF
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer
2016
·
Filippo Pietrantonio
, Daniele Oddo
, et al.
·
Cancer Discovery
·
112
PDF
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
2016
·
Alice Bartolini
, Sabrina Cardaci
, et al.
·
Clinical Cancer Research
·
73
PDF
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
2017
·
Chiara Riganti
, Marcello Francesco Lingua
, et al.
·
OncoImmunology
·
59
PDF
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer
2017
·
Daniele Oddo
, Giulia Siravegna
, et al.
·
British Journal of Cancer
·
39
PDF
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
2018
·
Mariangela Russo
, Simona Lamba
, et al.
·
Nature Communications
·
22
PDF
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
2023
·
Francesca Bersani
, Francesca Picca
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
13
PDF
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein
2022
·
Elisabetta Marini
, Marco Marino
, et al.
·
Molecules
·
12
PDF
DNA demethylation triggers cell free DNA release in colorectal cancer cells
2024
·
Valeria Pessei
, Marco Macagno
, et al.
·
Genome Medicine
·
11
PDF
Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models
2024
·
Federica Maione
, Daniele Oddo
, et al.
·
Molecular Oncology
·
7
Calreticulin exposure is a critical mediator of high-dose vitamin C-induced immune surveillance in the tumor microenvironment
2026
·
Alessandro Cavaliere
, Federica Maione
, et al.
·
Molecular Cancer Research
PDF
Author response for "Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models"
2023
·
Federica Maione
, Daniele Oddo
, et al.
·
Publons reviews and discussion
Author response for "Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models"
2023
·
Federica Maione
, Daniele Oddo
, et al.
·
Publons reviews and discussion
Cell Model Network-UK from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
PDF
Data from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
Supplementary Methods, Tables S1 - S2 from MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
2023
·
Filippo Pietrantonio
, Daniele Oddo
, et al.
PDF
Supplementary Figures S1 - S3 from MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
2023
·
Filippo Pietrantonio
, Daniele Oddo
, et al.
Supplementary Figure Legends from MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
2023
·
Filippo Pietrantonio
, Daniele Oddo
, et al.
Supplementary Table 1 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
Supplementary Figure 4 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
PDF
Supplementary Figure 3 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
Supplementary Figure 5 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
Supplementary Figure 1 from Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
2023
·
Gabriele Picco
, Chiara M. Cattaneo
, et al.
PDF
Show more works
View as search
Works count:
52
Citation count:
856
H-index:
11
I10-index:
11
Year
Topic
Type